Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development

References

• Sharp PM, Shaw GM, Hahn BH. Simian immunodeficiency virus infection of chimpanzees. J. Virol.79(7), 3891–3902 (2005).
   PubMed Web of Science ®Google Scholar
• Keele BF, Van Heuverswyn F, Li Y et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science313(5786), 523–526 (2006).
   PubMed Web of Science ®Google Scholar
• Heeney JL, Dalgleish AG, Weiss RA. Origins of HIV and the evolution of resistance to AIDS. Science313(5786), 462–466 (2006).
   PubMed Web of Science ®Google Scholar
• Damond F, Worobey M, Campa P et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res. Hum. Retroviruses20(6), 666–672 (2004).
   PubMed Web of Science ®Google Scholar
• Santiago ML, Range F, Keele BF et al. Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d’Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2. J. Virol.79(19), 12515–12527 (2005).
   PubMed Web of Science ®Google Scholar
• Yamaguchi J, Devare SG, Brennan CA. Identification of a new HIV-2 subtype based on phylogenetic analysis of full-length genomic sequence. AIDS Res. Hum. Retrovir.16(9), 925–930 (2000).
   PubMed Web of Science ®Google Scholar
• Apetrei C, Robertson DL, Marx PA. The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front. Biosci.9, 225–254 (2004).
   PubMed Web of Science ®Google Scholar
• Marx PA, Apetrei C, Drucker E. AIDS as a zoonosis? Confusion over the origin of the virus and the origin of the epidemics. J. Med. Primatol.33(5–6), 220–226 (2004).
   PubMed Web of Science ®Google Scholar
• Murphey-Corb M, Martin LN, Rangan SR et al. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature321(6068), 435–437 (1986).
   PubMed Web of Science ®Google Scholar
• Allan JS, Short M, Taylor ME et al. Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J. Virol.65(6), 2816–2828 (1991).
   PubMedGoogle Scholar
• Hirsch VM, Johnson PR. Pathogenic diversity of simian immunodeficiency viruses. Virus Res.32(2), 183–203 (1994).
   PubMed Web of Science ®Google Scholar
• Hirsch VM, Dapolito G, Goeken R, Campbell BJ. Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr. Opin. Genet. Dev.5(6), 798–806 (1995).
   PubMedGoogle Scholar
• Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest.117(11), 3148–3154 (2007).
   PubMedGoogle Scholar
• Lowenstine LJ, Pedersen NC, Higgins J et al. Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int. J. Cancer38(4), 563–574 (1986).
   PubMed Web of Science ®Google Scholar
• Ohta Y, Masuda T, Tsujimoto H et al. Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int. J. Cancer41(1), 115–122 (1988).
   PubMed Web of Science ®Google Scholar
• Diop OM, Gueye A, Ayouba A et al.Simian Immunodeficiency Viruses and the Origin of HIVs (2nd Edition). Kluwer Academic/Plenum Publishers, Dordrecht, The Netherlands (2002).
   Google Scholar
• Nerrienet E, Amouretti X, Müller-Trutwin MC et al. Phylogenetic analysis of SIV and STLV type I in mandrills (Mandrillus sphinx): indications that intracolony transmissions are predominantly the result of male-to-male aggressive contacts. AIDS Res. Hum. Retroviruses14(9), 785–796 (1998).
   PubMedGoogle Scholar
• Souquière S, Bibollet-Ruche F, Robertson DL et al. Wild Mandrillus sphinx are carriers of two types of lentivirus. J. Virol.75(15), 7086–7096 (2001).
   PubMedGoogle Scholar
• Apetrei C, Metzger MJ, Robinson D et al. Detection and partial characterization of new simian immunodeficiency virus (SIVsm) strains from bush meat samples from rural Sierra Leone. J. Virol.79(14), 2631–2636 (2005).
   PubMedGoogle Scholar
• VandeWoude S, Apetrei C. Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin. Microbiol. Rev.19(4), 728–762 (2006).
   PubMedGoogle Scholar
• Van Heuverswyn F, Li Y, Neel C et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature444(7116), 164 (2006).
   PubMed Web of Science ®Google Scholar
• Peeters M, Courgnaud V, Abela B. Genetic diversity of lentiviruses in non-human primates. AIDS Rev.3, 3–10 (2001).
   Google Scholar
• Van Heuverswyn F, Peeters M. The origins of HIV and implications for the global epidemic. Curr. Infect. Dis. Rep.9(4), 338–346 (2007).
   PubMedGoogle Scholar
• McCune JM, Namikawa R, Shih CC, Rabin L, Kaneshima H. Pseudotypes in HIV-infected mice. Science250(4984), 1152–1154 (1990).
   PubMedGoogle Scholar
• Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA. Human immunodeficiency virus infection of human-PBL-SCID mice. Science251(4995), 791–794 (1991).
   PubMed Web of Science ®Google Scholar
• Baenziger S, Tussiwand R, Schlaepfer E et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-γc-/- mice. Proc. Natl Acad. Sci. USA103(43), 15951–15956 (2006).
   PubMed Web of Science ®Google Scholar
• Jamieson BD, Zack JA. Murine models for HIV disease. AIDS13(Suppl. A), S5–S11 (1999).
   PubMedGoogle Scholar
• Lorès P, Boucher V, Mackay C, Pla M et al. Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res. Hum. Retroviruses8(12), 2063–2071 (1992).
   PubMedGoogle Scholar
• Browning J, Horner JW, Pettoello-Mantovani M et al. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc. Natl Acad. Sci. USA94(26), 14637–14641 (1997).
   PubMed Web of Science ®Google Scholar
• Boberg A, Bråve A, Johansson S, Wahren B, Hinkula J, Rollman E. Murine models for HIV vaccination and challenge. Expert Rev. Vaccines7(1), 117–130 (2008).
   PubMed Web of Science ®Google Scholar
• Fultz PN, McClure HM, Swenson RB et al. Persistent infection of chimpanzees with human T-lymphotropic virus type III/LAV: a potential model for acquired immunodeficiency syndrome. J. Virol.58(1), 116–124 (1986).
   PubMed Web of Science ®Google Scholar
• Rutjens E, Balla-Jhagjhoorsingh S, Verschoor E, Bogers W, Koopman G, Heeney J. Lentivirus infections and mechanisms of disease resistance in chimpanzees. Front. Biosci.8, 1134–1145 (2003).
   Web of Science ®Google Scholar
• Gougeon ML, Lecoeur H, Boudet F et al. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J. Immunol.158(6), 2964–2976 (1997).
   PubMedGoogle Scholar
• Juompan LY, Hutchinson K, Montefiori DC, Nidtha S, Villinger F, Novembre FJ. Analysis of the immune responses in chimpanzees infected with HIV type 1 isolates. AIDS Res. Hum. Retroviruses24(4), 573–586 (2008).
   PubMedGoogle Scholar
• Novembre FJ, Saucier M, Anderson DC et al. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol.71(5), 4086–4091 (1997).
   PubMed Web of Science ®Google Scholar
• O’Neil SP, Novembre FJ, Hill AB et al. Progressive infection in a subset of HIV-1-positive chimpanzees. J. Infect. Dis.182(4), 1051–1062 (2000).
   PubMed Web of Science ®Google Scholar
• Dormant D, Livartowski J, Chamaret S et al. HIV-2 in rhesus monkeys: serological, virological and clinical results. Intervirology.30(Suppl. 1), 59–65 (1989).
   PubMedGoogle Scholar
• Agy MB, Frumkin LR, Corey L et al. Infection of Macaca nemestrina by human immunodeficiency virus type 1. Science257, 103–106 (1992).
   PubMedGoogle Scholar
• Otten RA, Brown BG, Simon M et al. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. AIDS8(3), 297–306 (1994).
   PubMedGoogle Scholar
• Barnett SW, Murthy KK, Herndier BG, Levy JA. An AIDS-like condition induced in baboons by HIV-2. Science266 (5185), 642–646 (1994).
   PubMedGoogle Scholar
• Locher CP, Barnett SW, Herndier BG et al. Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. Arch. Pathol. Lab. Med.122(6), 523–533 (1998).
   PubMedGoogle Scholar
• Locher CP, Witt SA, Herndier BG et al. Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons. J. Virol.77(1), 77–83 (2003).
   PubMedGoogle Scholar
• Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature427(6977), 848–853 (2004).
   PubMed Web of Science ®Google Scholar
• Stremlau M. GE Prize-winning essay. Why Old World monkeys are resistant to HIV-1. Science318(5856), 1565–1566 (2007).
   PubMed Web of Science ®Google Scholar
• Hatziioannou T, Cowan S, Von Schwedler UK, Sundquist WI, Bieniasz PD. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J. Virol.78(11), 6005–6012 (2004).
   PubMedGoogle Scholar
• Nomaguchi M, Doi N, Kamada K, Adachi A. Species barrier of HIV-1 and its jumping by virus engineering. Rev. Med. Virol.18(4), 261–275 (2008).
   PubMed Web of Science ®Google Scholar
• Wilson SJ, Webb BL, Maplanka C et al. Rhesus macaque TRIM5 alleles have divergent anti-retroviral specificities. J. Virol.82(14), 7243–7247 (2008).
   PubMedGoogle Scholar
• Daniel MD, Letvin NL, King NW et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science228(4704), 1201–1204 (1985).
   PubMed Web of Science ®Google Scholar
• Letvin NL, Daniel MD, Sehgal PK et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science230(4721), 71–73 (1985).
   PubMed Web of Science ®Google Scholar
• Naidu YM, Kestler HW 3rd, Li Y et al. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. J. Virol.62(12), 4691–4696 (1988).
   PubMedGoogle Scholar
• Kestler H, Kodama T, Ringler D et al. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science248(4959), 1109–1112 (1990)
   PubMed Web of Science ®Google Scholar
• Hirsch VM, Dapolito G, Johnson PR et al. Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J. Virol.69(2), 955–967 (1995).
   PubMed Web of Science ®Google Scholar
• Apetrei C, Kaur A, Lerche NW et al. Molecular epidemiology of simian immunodeficiency virus SIVsm in US primate centers unravels the origin of SIVmac and SIVstm. J. Virol.79(14), 8991–9005 (2005).
   PubMed Web of Science ®Google Scholar
• Davison-Fairburn B, Blanchard J, Hu FS et al. Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation. J. Med. Primatol.19(3–4), 381–393 (1990).
   PubMedGoogle Scholar
• Fazely F, Sharma PL, Fratazzi C et al. Simian immunodeficiency virus infection via amniotic fluid: a model to study fetal immunopathogenesis and prophylaxis. J. Acquir. Immune. Defic. Syndr.6(2), 107–114 (1993).
   PubMedGoogle Scholar
• Amedee AM, Lacour N, Ratterree M. Mother-to-infant transmission of SIV via breast-feeding in rhesus macaques. J. Med. Primatol.32(4–5), 187–193 (2003).
   PubMedGoogle Scholar
• Rychert J, Lacour N, Amedee AM. Genetic analysis of simian immunodeficiency virus expressed in milk and selectively transmitted through breastfeeding. J. Virol.80(8), 3721–3731 (2006).
   PubMedGoogle Scholar
• Baba TW, Trichel AM, An L et al. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science272(5267), 1486–1489 (1996).
   PubMedGoogle Scholar
• Miller CJ, Alexander NJ, Sutjipto S, Lackner AA et al. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol.63(10), 4277–4284 (1989).
   PubMedGoogle Scholar
• Miller CJ, Marthas M, Torten J et al. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol.68(10), 6391–6400 (1994).
   PubMedGoogle Scholar
• Morales JC, Melnick DJ. Phylogenetic relationships of the macaques (Cercopithecidae: Macaca), as revealed by high resolution restriction site mapping of mitochondrial ribosomal genes. J. Hum. Evol.34(1), 1–23 (1998).
   PubMed Web of Science ®Google Scholar
• Tosi AJ, Morales JC, Melnick DJ. Comparison of Y chromosome and mtDNA phylogenies leads to unique inferences of macaque evolutionary history. Mol. Phylogenet. Evol.17(2), 133–144 (2000).
   PubMed Web of Science ®Google Scholar
• McClure J, Schmidt AM, Rey-Cuille MA et al. Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina. J. Med. Primatol.29(3–4), 114–126 (2000).
   PubMedGoogle Scholar
• Locher CP, Witt SA, Herndier BG, Tenner-Racz K, Racz P, Levy JA. Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development. Immunol. Rev.183, 127–140 (2001).
   PubMed Web of Science ®Google Scholar
• van’t Wout AB, Kootstra NA, Mulder-Kampinga GA et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest.94(5), 2060–2067 (1994).
   PubMed Web of Science ®Google Scholar
• Scarlatti G, Tresoldi E, Björndal A et al.In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med.3(11), 1259–1265 (1997).
   PubMed Web of Science ®Google Scholar
• Picker LJ, Hagen SI, Lum R et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med.200(10), 1299–1314 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang Z, Schuler T, Zupancic M et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science.286(5443), 1353–1357 (1999).
   PubMed Web of Science ®Google Scholar
• Hu SL. Non-human primate models for AIDS vaccine research. Curr. Drug Targets Infect. Disord.5(2), 193–201 (2005).
   PubMedGoogle Scholar
• Le Rouzic E, Benichou S. The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology2, 11 (2005).
   PubMedGoogle Scholar
• Uberla K, Stahl-Hennig C, Böttiger D et al. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors. Proc. Natl Acad. Sci. USA92(18), 8210–8214 (1995).
   PubMed Web of Science ®Google Scholar
• Shioda T, Levy JA, Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regionsof the envelope gp120 gene. Nature349(6305), 167–169 (1991).
   PubMed Web of Science ®Google Scholar
• Mori K, Ringler DJ, Kodama T, Desrosiers RC. Complex determinants of macrophage tropism in Env of simian immunodeficiency virus. J. Virol.66(4), 2067–2075 (1992).
   PubMedGoogle Scholar
• Robert-Guroff M, Aldrich K, Muldoon R et al. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J. Virol.66(6), 3602–3608 (1992).
   PubMedGoogle Scholar
• Emini EA, Schleif WA, Nunberg JH et al. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature355(6362), 728–730 (1992).
   PubMed Web of Science ®Google Scholar
• Letvin NL, Robinson S, Rohne D et al. Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian–human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope. J. Virol.75(9), 4165–4175 (2001).
   PubMedGoogle Scholar
• Javaherian K, Langlois AJ, Schmidt S et al. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA89(4), 1418–1422 (1992).
   PubMed Web of Science ®Google Scholar
• Almond N, Jenkins A, Heath AB, Taffs LF, Kitchin P. The genetic evolution of the envelope gene of simian immunodeficiency virus in cynomolgus macaques infected with a complex virus pool. Virology191(2), 996–1002 (1992) .
   PubMedGoogle Scholar
• Sato S, Johnson W. Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS. Curr. HIV Res.5(6), 594–607 (2007).
   PubMedGoogle Scholar
• Shibata R, Kawamura M, Sakai H, Hayami M, Ishimoto A, Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol.65(7), 3514–3520 (1991).
   PubMed Web of Science ®Google Scholar
• Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquir. Immune Defic. Syndr.5(7), 639–646 (1992).
   PubMed Web of Science ®Google Scholar
• Sakuragi S, Shibata R, Mukai R et al. Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus. J. Gen. Virol.73(11), 2983–2987 (1992).
   PubMedGoogle Scholar
• Reimann KA, Li JT, Veazey R et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate Env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol.70(10), 6922–6928 (1996).
   PubMed Web of Science ®Google Scholar
• Karlsson GB, Halloran M, Li J et al. Characterization of molecularly cloned simian–human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J. Virol.71(6), 4218–4225 (1997).
   PubMedGoogle Scholar
• Ishimatsu M, Suzuki H, Akiyama H, Miura T, Hayami M, Ido E. Construction of a novel SHIV having an HIV-1-derived protease gene and its infection to rhesus macaques: a useful tool for in vivo efficacy tests of protease inhibitors. Microbes Infect. 2007 9(4), 475–482 (2007).
   PubMed Web of Science ®Google Scholar
• Akiyama H, Ishimatsu M, Miura T, Hayami M, Ido E. Construction and infection of a new simian/human immunodeficiency chimeric virus (SHIV) containing the integrase gene of the human immunodeficiency virus type 1 genome and analysis of its adaptation to monkey cells. Microbes Infect.10(5), 531–539 (2008).
   PubMedGoogle Scholar
• Nishimura Y, Igarashi T, Donau OK et al. Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc. Natl Acad. Sci. USA101(33), 12324–12329 (2004).
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Brown CR, Mattapallil JJ et al. Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian–human immunodeficiency viruses in macaques. Proc. Natl Acad. Sci. USA102(22), 8000–8005 (2005).
   PubMed Web of Science ®Google Scholar
• Igarashi T, Brown CR, Byrum RA et al. Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous. J. Virol.76(1), 379–391 (2002).
   PubMedGoogle Scholar
• Endo Y, Igarashi T, Nishimura Y et al. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus. J. Virol.74(15), 6935–6945 (2000).
   PubMedGoogle Scholar
• Joag SV, Li Z, Foresman L et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol.70(5), 3189–3197 (1996).
   PubMed Web of Science ®Google Scholar
• Borsetti A, Baroncelli S, Maggiorella MT et al. Viral outcome of simian–human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys. Arch. Virol.153(3), 463–472 (2008).
   PubMed Web of Science ®Google Scholar
• Igarashi T, Endo Y, Nishimura Y et al. Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes. J. Virol.77(20), 10829–10840 (2003).
   PubMedGoogle Scholar
• Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science284(5415), 816–819 (1999).
   PubMedGoogle Scholar
• Hsu M, Ho SH, Balfe P et al. A CCR5-tropic simian–HIV molecular clone capable of inducing AIDS in rhesus macaques. J. Acquir. Immune Defic. Syndr.40(4), 383–387 (2005).
   PubMed Web of Science ®Google Scholar
• Hsu M, Buckner C, Harouse J et al. Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVsf162p3 gp120 variants. J. Med. Primatol.32(4–5), 211–217 (2003).
   PubMedGoogle Scholar
• Mascola JR, Lewis MG, Stiegler G et al. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol.73(5), 4009–4018 (1999).
   PubMed Web of Science ®Google Scholar
• Amara RR, Smith JM, Staprans SI et al. Critical role for Env as well as Gag-Pol in control of a simian–human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J. Virol.76(15), 6138–6146 (2002).
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Igarashi T, Haigwood NL et al. Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. Proc. Natl Acad. Sci. USA100(25), 15131–15136 (2003).
   PubMed Web of Science ®Google Scholar
• Cafaro A, Caputo A, Fracasso C et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med.5(6), 643–650 (1999).
   PubMed Web of Science ®Google Scholar
• Barouch DH, Santra S, Schmitz JE et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science290(5491), 486–492 (2000).
   PubMed Web of Science ®Google Scholar
• Rose NF, Marx PA, Luckay A et al. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell106(5), 539–549 (2001).
   PubMed Web of Science ®Google Scholar
• Chen X, Scala G, Quinto I et al. Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat. Med.7(11), 1225–1231 (2001).
   PubMed Web of Science ®Google Scholar
• Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature415(6869), 331–335 (2002).
   PubMed Web of Science ®Google Scholar
• Barnett SW, Srivastava IK, Kan E et al. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS22(3), 339–348 (2008).
   PubMed Web of Science ®Google Scholar
• Stolte-Leeb N, Bieler K, Köstler J et al. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone. Viral Immunol.21(2), 235–246 (2008).
   PubMedGoogle Scholar
• Feinberg MB, Moore JP. AIDS vaccine models: challenging challenge viruses. Nat. Med.8(3), 207–210 (2002).
   PubMed Web of Science ®Google Scholar
• Koff WC, Johnson PR, Watkins DI et al. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol.7(1), 19–23 (2006).
   PubMed Web of Science ®Google Scholar
• Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med.14(6), 617–621 (2008).
   PubMed Web of Science ®Google Scholar
• Casimiro DR, Wang F, Schleif WA et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. (24), 15547–15555 (2005).
   PubMedGoogle Scholar
• McDermott AB, O’Connor DH, Fuenger S et al. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. Virology79(24), 15556–15566 (2005).
   Google Scholar
• Seth A, Ourmanov I, Schmitz JE et al. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag–Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge. J. Virol.74(6), 2502–2509 (2000).
   PubMed Web of Science ®Google Scholar
• Horton H, Vogel TU, Carter DK et al. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J. Virol.76(14), 7187–7202 (2002).
   PubMed Web of Science ®Google Scholar
• Pal R, Venzon D, Letvin NL et al. ALVAC-SIV-gag–pol–env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J. Virol.76(1), 292–302 (2002).
   PubMed Web of Science ®Google Scholar
• Patterson LJ, Malkevitch N, Venzon D et al. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus–SIV multigene vaccine priming and subunit boosting. J. Virol.78(5), 2212–2221 (2004).
   PubMed Web of Science ®Google Scholar
• Wilson NA, Reed J, Napoe GS et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol.80(12), 5875–5885 (2006).
   PubMed Web of Science ®Google Scholar
• Negri DR, Baroncelli S, Catone S et al. Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge. J. Gen. Virol.85(5), 1191–1201 (2004).
   PubMed Web of Science ®Google Scholar
• Whitney JB, Ruprecht RM. Live attenuated HIV vaccines: pitfalls and prospects. Curr. Opin. Infect. Dis.17(1), 17–26 (2004).
   PubMed Web of Science ®Google Scholar
• Shibata RT, Igarashi N, Haigwood A et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med.5(2), 204–210 (1999).
   PubMed Web of Science ®Google Scholar
• Ferrantelli F, Rasmussen RA, Buckley KA et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian–human immunodeficiency virus by human anti-HIV monoclonal antibodies. J. Infect. Dis.189(12), 2167–2173 (2004).
   PubMed Web of Science ®Google Scholar
• Ferrantelli F, Buckley KA, Rasmussen RA et al. Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques. Virology358(1), 69–78 (2007).
   PubMed Web of Science ®Google Scholar
• Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull.58, 19–42 (2001).
   PubMed Web of Science ®Google Scholar
• Xu R, Srivastava IK, Kuller L et al. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Virology349(2), 276–289 (2006).
   PubMedGoogle Scholar
• Baba TW, Liska V, Khimani AH et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med.5(2), 194–203 (1999).
   PubMed Web of Science ®Google Scholar
• Liniger M, Zuniga A, Naim HY. Use of viral vectors for the development of vaccines. Expert Rev. Vaccines6(2), 255–266 (2007).
   PubMed Web of Science ®Google Scholar
• Robert-Guroff M. Replicating and non-replicating viral vectors for vaccine development. Curr. Opin. Biotechnol.18(6), 546–556 (2007).
   PubMed Web of Science ®Google Scholar
• Smith SM, Holland B, Russo C, Dailey PJ, Marx PA, Connor RI. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res. Hum. Retroviruses15(18), 1691–1701 (1999).
   PubMedGoogle Scholar
• Parker RA, Regan MM, Reimann KA. Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics. J. Virol.75(22), 11234–11238 (2001).
   PubMedGoogle Scholar
• ten Haaft P, Almond N, Biberfeld G et al. Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. J. Med. Primatol.30(4), 207–214 (2001).
   PubMed Web of Science ®Google Scholar
• Davenport MP, Ribeiro RM, Chao DL, Perelson AS. Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus. J. Virol.78(20), 11340–11351 (2004).
   PubMedGoogle Scholar
• Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: what we know, what we don’t know, what we should know. Nat. Med.10(8), 806–810 (2004).
   PubMed Web of Science ®Google Scholar
• Gauduin MC, Glickman RL, Ahmad S, Yilma T, Johnson RP. Characterization of SIV-specific CD4+ T-helper proliferative responses in macaques immunized with live-attenuated SIV. J. Med. Primatol.28(4–5), 233–241 (1999).
   PubMedGoogle Scholar
• Walker BD. Elite control of HIV infection: implications for vaccines and treatment. Top. HIV Med.15(4), 134–136 (2007).
   PubMedGoogle Scholar
• Walker BD, Burton DR. Toward an AIDS vaccine. Science320(5877), 760–764 (2008).
   PubMed Web of Science ®Google Scholar
• Veazey R, Lackner A. The mucosal immune system and HIV-1 infection. AIDS Rev.5(4), 245–252 (2003).
   PubMedGoogle Scholar
• Li Q, Duan L, Estes JD, Ma ZM et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature434(7037), 1148–1152 (2005).
   PubMed Web of Science ®Google Scholar
• Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature434(7037), 1093–1097 (2005).
   PubMed Web of Science ®Google Scholar
• Wolfheim JH. Primates of the World: Distribution, Abundance, and Conservation. University of Washington Press, WA, USA (1983).
   Google Scholar
• Groves CP. Primate Taxonomy. Smithsonian Institute Press, DC, USA (2001).
   Google Scholar
• Fooden J. Systematic review of the rhesus macaque, Macaca mulatta (Zimmermann, 1780). Field Zool.96, 1–180 (2000).
   Google Scholar
• Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med.2(4), 405–411 (1996).
   PubMed Web of Science ®Google Scholar
• Kaizu M, Borchardt GJ, Glidden CE et al. Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics59(9), 693–703 (2007).
   PubMedGoogle Scholar
• Rhesus Macaque Genome Sequencing and Analysis Consortium; Gibbs RA, Rogers J, Katze MG et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science316(5822), 222–234 (2007).
   PubMed Web of Science ®Google Scholar
• Allen , TM, Mothe BR, Sidney J et al. CD8+ lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule Mamu-A*01: implications for vaccine design and testing. J. Virol.75(2), 738–749 (2001).
   PubMedGoogle Scholar
• Zhang ZQ, Fu TM, Casimiro DR et al.Mamu-A*01 allele-mediated attenuation of disease progression in simian–human immunodeficiency virus infection. J. Virol.76(24), 12845–12854 (2002).
   PubMed Web of Science ®Google Scholar
• Mothé BR, Weinfurter J, Wang C et al. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol.77(4), 2736–2740 (2003).
   PubMed Web of Science ®Google Scholar
• Evans DT, Jing P, Allen TM et al. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression. J. Virol.74(16), 7400–7410 (2000).
   PubMedGoogle Scholar
• Seaman MS, Santra S, Newberg MH et al. Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys. J. Virol.79(8), 4580–4588 (2005).
   PubMedGoogle Scholar
• O’Connor DH, Mothe BR, Weinfurter JT et al. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol.77(16), 9029–9040 (2003).
   PubMedGoogle Scholar
• Yant LJ, Friedrich TC, Johnson RC et al. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol.80(10), 5074–5077 (2006).
   PubMed Web of Science ®Google Scholar
• Loffredo JT, Maxwell J, Qi Y et al.Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol.81(16), 8827–8832 (2007).
   PubMed Web of Science ®Google Scholar
• Mühl T, Krawczak M, Ten Haaft P, Hunsmann G, Sauermann U. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol.169(6), 3438–3446 (2002).
   PubMedGoogle Scholar
• Knapp LA, Lehmann E, Piekarczyk MS, Urvater JA,Watkins DI. A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. Tissue Antigens50(6), 657–661 (1997).
   PubMedGoogle Scholar
• Cohen J AIDS research. Vaccine studies stymied by shortage of animals. Science287(5455), 959–960 (2000).
   PubMedGoogle Scholar
• Lerche NW, Osborn KG. Simian retrovirus infections: potential confounding variables in primate toxicology studies. Toxicol. Pathol.31(Suppl.), 103–110 (2003).
   PubMedGoogle Scholar
• Lairmore MD, Lerche NW, Schultz KT et al. SIV, STLV-I and type D retrovirus antibodies in captive rhesus macaques and immunoblot reactivity to SIV p27 in human and rhesus monkey sera. AIDS Res. Hum. Retroviruses6(11), 1233–1238 (1990).
   PubMedGoogle Scholar
• Morton WR, Agy MB, Capuano SV, Grant RF. Specific pathogen-free macaques: definition, history, and current production. ILAR J.49(2), 137–144 (2008).
   PubMed Web of Science ®Google Scholar
• Champoux M, Higley JD, Suomi SJ. Behavioral and physiological characteristics of Indian and Chinese–Indian hybrid rhesus macaque infants. Dev. Psychobiol.31(1), 49–63 (1997).
   PubMedGoogle Scholar
• Capitanio JP, Mendoza SP, Lerche NW. Individual differences in peripheral blood immunological and hormonal measures in adult male rhesus macaques (Macaca mulatta): evidence for temporal and situational consistency. Am. J. Primatol.44(1), 29–41 (1998).
   PubMedGoogle Scholar
• Kanthaswamy S, Smith DG. Effects of geographic origin on captive Macaca mulatta mitochondrial DNA variation. Comp. Med.54(2), 193–201 (2004).
   PubMedGoogle Scholar
• Smith DG, McDonough J. Mitochondrial DNA variation in Chinese and Indian rhesus macaques (Macaca mulatta). Am. J. Primatol.65(1), 1–25 (2005).
   PubMedGoogle Scholar
• Kyes RC, Jones-Engel L, Chalise MK et al. Genetic characterization of rhesus macaques (Macaca mulatta) in Nepal. Am. J. Primatol.68(5), 445–455 (2006).
   PubMedGoogle Scholar
• Ferguson B, Street SL, Wright H et al. Single nucleotide polymorphisms (SNPs) distinguish Indian-origin and Chinese-origin rhesus macaques (Macaca mulatta). BMC Genomics8, 43 (2007).
   PubMedGoogle Scholar
• Joag SV, Stephens EB, Adams RJ, Foresman L, Narayan O. Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology200(2), 436–446 (1994).
   PubMedGoogle Scholar
• Marthas ML, Lu D, Penedo MC, Hendrickx AG, Miller CJ. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses. AIDS Res. Hum. Retroviruses17(15), 1455–1466 (2001).
   PubMed Web of Science ®Google Scholar
• Ling B, Veazey RS, Luckay A, Penedo C, Xu K, Lifson JD, Marx PA. SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS16(11), 1489–1496 (2002).
   PubMed Web of Science ®Google Scholar
• Trichel AM, Rajakumar PA, Murphey-Corb M. Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J. Med. Primatol.31(4–5), 171–178 (2002).
   PubMed Web of Science ®Google Scholar
• Reimann KA, Parker RA, Seaman MS et al. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J. Virol.79(14), 8878–8885 (2005).
   PubMed Web of Science ®Google Scholar
• Marcondes MC, Penedo MC, Lanigan C et al. Simian immunodeficiency virus-induced CD4+ T cell deficits in cytokine secretion profile are dependent on monkey origin. Viral. Immunol.19(4), 679–689 (2006).
   PubMedGoogle Scholar
• Monceaux V, Viollet L, Petit F et al. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J. Virol.81(24), 13865–13875 (2007).
   PubMedGoogle Scholar
• Crowe S. SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans, by Stellbrink et al.AIDS17(Suppl. 4), S107–S108 (2003).
   Google Scholar
• Burdo TH, Marcondes MC, Lanigan CM, Penedo MC, Fox HS. Susceptibility of Chinese rhesus monkeys to SIV infection. AIDS19(15), 1704–1706 (2005).
   PubMedGoogle Scholar
• Otting N, de Vos-Rouweler AJ, Heijmans CM, de Groot NG, Doxiadis GG, Bontrop RE. MHC class IA region diversity and polymorphism in macaque species. Immunogenetics59(5), 367–375 (2007).
   PubMedGoogle Scholar
• Karl JA, Wiseman RW, Campbell KJ et al. Identification of MHC class I sequences in Chinese-origin rhesus macaques. Immunogenetics60(1), 37–46 (2008).
   PubMedGoogle Scholar
• Sussman RW, Tattersall I. Distribution, abundance, and putative ecological strategy of Macaca fascicularis on the Island of Mauritius, Southwestern Indian Ocean. Folia Primatology46(1), 28–43 (1986).
   Google Scholar
• Republic of Mauritius, Ministry of Economic Development. Digest of environment statistics. Central Statistics Office, Port Louis, Mauritius (2002).
   Google Scholar
• Krebs KC, Jin Z, Rudersdorf R, Hughes AL, O’Connor DH. Unusually high frequency MHC class I alleles in Mauritian origin cynomolgus macaques. J. Immunol.175(8), 5230–5239 (2005).
   PubMedGoogle Scholar
• Geretti AM, Hulskotte EG, Dings J, van Baalen MEM, Amerongen CA, Osterhaus AD. CD8 cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26. J. Gen. Virol.78(4), 821–824 (1987).
   Google Scholar
• Negri DR, Borghi M, Baroncelli S et al. Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus. J. Gen. Virol.87(11), 3385–3392 (2006).
   PubMedGoogle Scholar
• Blancher A, Tisseyre P, Dutaur M et al. Study of Cynomolgus monkey (Macaca fascicularis) MhcDRB (Mafa-DRB) polymorphism in two populations. Immunogenetics58(4), 269–282 (2006).
   PubMed Web of Science ®Google Scholar
• O’Connor SL, Blasky AJ, Pendley CJ et al. Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques. Immunogenetics59(6), 449–462 (2007).
   PubMed Web of Science ®Google Scholar
• Wiseman RW, Wojcechowskyj JA, Greene JM et al. Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius. J. Virol.81(1), 349–361 (2007).
   PubMedGoogle Scholar
• Boniotto M, Tossi A, Crovella S. β-defensin 2 in the rhesus monkey (Macaca mulatta) and the long-tailed macaque (M. fascicularis). Clin. Diagn. Lab. Immunol.9(2), 503–504 (2002).
   PubMedGoogle Scholar
• Biassoni R, Fogli M, Cantoni C et al. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection. J. Immunol.174(9), 5695–5705 (2005).
   PubMed Web of Science ®Google Scholar
• Dioszeghy V, Benlhassan-Chahour K, Delache B et al. Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression. J. Virol.80(1), 236–245 (2006).
   PubMed Web of Science ®Google Scholar
• Baroncelli S, Negri DR, Rovetto C et al. Characterization of α-defensins plasma levels in Macaca fascicularis and correlations with virological parameters during SHIV89.6Pcy11 experimental infection. AIDS Res. Hum. Retroviruses23(2), 287–296 (2007).
   PubMedGoogle Scholar
• Karlsson I, Malleret B, Brochard P et al. FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load. J. Virol.81(24), 13444–13455 (2007).
   PubMed Web of Science ®Google Scholar
• Cara A, Reitz MS Jr. New insight on the role of extrachromosomal retroviral DNA. Leukemia11(9), 1395–1399 (1997).
   PubMed Web of Science ®Google Scholar
• De Milito A, Titanji K, Zazzi M. Surrogate markers as a guide to evaluate response to antiretroviral therapy. Curr. Med. Chem.10(5), 349–365 (2003).
   PubMedGoogle Scholar
• Cara A, Maggiorella MT, Bona R et al. Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA. Virology324(2), 531–539 (2004).
   PubMedGoogle Scholar
• Rosenberg YJ, Cafaro A, Brennan T et al. Characteristics of the CD8+ lymphocytosis during primary simian immunodeficiency virus infections. AIDS11(8), 959–968 (1997).
   PubMedGoogle Scholar
• Kourtis AP, Ibegbu CC, Scinicariello F, Oh CY, McClure HM. SHIV-KB9 infection of rhesus monkeys does not always cause disease-contribution of host immune factors and thymic output. Virology303(1), 47–57 (2002).
   PubMedGoogle Scholar
• Richardson MW, Sverstiuk AE, Silvera P et al. T-cell receptor excision circles (TREC) in SHIV89.6P and SIVmac251 models of HIV-1 infection. DNA Cell. Biol.23(1), 1–13 (2004).
   PubMedGoogle Scholar
• Motohara M, Ibuki K, Miyake A et al. Impaired T-cell differentiation in the thymus at the early stages of acute pathogenic chimeric simian–human immunodeficiency virus (SHIV) infection in contrast to less pathogenic SHIV infection. Microbes Infect8(6), 1539–1549 (2006).
   PubMedGoogle Scholar
• Bona R, Macchia I, Baroncelli S et al. T cell receptor excision circles (TRECs) analysis during acute intrarectal infection of cynomolgus monkeys with pathogenic chimeric simian human immunodeficiency virus. Virus Res.126(1–2), 86–95 (2007).
   PubMedGoogle Scholar
• Shinohara K, Sakai K, Ando S et al. A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey. J. Gen. Virol.80(5), 1231–1240 (1999).
   PubMedGoogle Scholar
• Kaizu M, Ami Y, Nakasone T et al. Higher levels of IL-18 circulate during primary infection of monkeys with a pathogenic SHIV than with a nonpathogenic SHIV. Virology313(1), 8–12 (2003).
   PubMedGoogle Scholar
• Frumkin LR, Agy MB, Coombs RW et al. Acute infection of Macaca nemestrina by human immunodeficiency virus type 1. Virology.195(2), 422–431 (1993).
   PubMed Web of Science ®Google Scholar
• Bosch ML, Schmidt A, Agy MB, Kimball LE, Morton WR. Infection of Macaca nemestrina neonates with HIV-1 via different routes of inoculation. AIDS11(13), 1555–1563 (1997).
   PubMedGoogle Scholar
• Agy MB, Schmidt A, Florey MJ et al. Serial in vivo passage of HIV-1 infection in Macaca nemestrina. Virology238(2), 336–343 (1997).
   PubMedGoogle Scholar
• Frumkin LR, Patterson BK, Leverenz JB et al. Infection of Macaca nemestrina brain with human immunodeficiency virus type 1. J. Gen. Virol.76(10), 2467–2476 (1995).
   PubMedGoogle Scholar
• Looney DJ, McClure J, Kent SJ et al. A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2(287) challenge. Virology242(1), 150–160 (1998).
   PubMedGoogle Scholar
• Radaelli A, Kraus G, Schmidt A et al. Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model. J. Virol.72(10), 7871–7884 (1998).
   PubMedGoogle Scholar
• Ho RJ, Larsen K, Kinman L et al. Characterization of a maternal–fetal HIV transmission model using pregnant macaques infected with HIV-2(287). J. Med. Primatol.30(3), 131–140 (2001).
   PubMedGoogle Scholar
• Herz AM, Robertson MN, Lynch JB et al. Viral dynamics of early HIV infection in neonatal macaques after oral exposure to HIV-2287: an animal model with implications for maternal–neonatal HIV transmission. J. Med. Primatol.31(1), 29–39 (2002).
   PubMedGoogle Scholar
• Worlein JM, Leigh J, Larsen K et al. Cognitive and motor deficits associated with HIV-2(287) infection in infant pigtailed macaques: a nonhuman primate model of pediatric neuro-AIDS. J. Neurovirol.11(1), 34–45 (2005).
   PubMed Web of Science ®Google Scholar
• Brennan G, Kozyrev Y, Kodama T, Hu SL. Novel TRIM5 isoforms expressed by Macaca nemestrina. J. Virol.81(22), 12210–12217 (2007).
   PubMedGoogle Scholar
• Stratov I, Dale CJ, Kent SJ. Phenotypic and kinetic analysis of effective simian–human immunodeficiency virus-specific T cell responses in DNA and fowlpox virus-vaccinated macaques. Virology337(2), 222–234 (2005).
   PubMedGoogle Scholar
• Wright EK Jr, Clements JE, Barber SA. Sequence variation in the CC-chemokine ligand 2 promoter of pigtailed macaques is not associated with the incidence or severity of neuropathology in a simian immunodeficiency virus model of human immunodeficiency virus central nervous system disease. J. Neurovirol.12(6), 411–419 (2006).
   PubMed Web of Science ®Google Scholar
• Batten CJ, De Rose R, Wilson KM et al. Comparative evaluation of simian, simian–human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. AIDS Res. Hum. Retroviruses22(6), 580–588 (2006).
   PubMed Web of Science ®Google Scholar
• Chase AJ, Sedaghat AR, German JR et al. Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection. J. Virol.81(23), 12748–12757 (2007).
   PubMed Web of Science ®Google Scholar
• Loh L, Petravic J, Batten CJ, Davenport MP, Kent SJ. Vaccination and timing influence SIV immune escape viral dynamics in vivo. PLoS Pathog.4(1), E12 (2008).
   Google Scholar
• Doria-Rose NA, Ohlen C, Polacino P et al. Multigene DNA priming–boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian–human immunodeficiency virus SHIV89.6P mucosal challenge. J. Virol.77(21), 11563–11577 (2003).
   PubMedGoogle Scholar
• Gorelick RJ, Benveniste RE, Lifson JD et al. Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost. J. Virol.74(24), 11935–11949 (2000).
   PubMed Web of Science ®Google Scholar
• Lifson JD, Rossio JL, Piatak M Jr et al. Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins. AIDS Res. Hum. Retroviruses20(7), 772–787 (2004).
   PubMedGoogle Scholar
• De Rose R, Batten CJ, Smith MZ et al. Comparative efficacy of subtype AE simian–human immunodeficiency virus priming and boosting vaccines in pigtail macaques. J. Virol.81(1), 292–300 (2007).
   PubMed Web of Science ®Google Scholar
• Lafont BA, Buckler-White A, Plishka R, Buckler C, Martin MA. Characterization of pig-tailed macaque classical MHC class I genes: implications for MHC evolution and antigen presentation in macaques. J. Immunol.171(2), 875–885 (2003).
   PubMedGoogle Scholar
• Wu J, Bassinger S, Montoya GD, Chavez L et al. Allelic diversity within the high frequency Mamu-A2*05/Mane-A2*05 (Mane-A*06)/Mafa-A2*05 family of macaque MHC-A loci. Tissue Antigens72(1), 29–38 (2008)
   PubMedGoogle Scholar
• Pratt BF, O’Connor DH, Lafont BA et al. MHC class I allele frequencies in pigtail macaques of diverse origin. Immunogenetics58(12), 995–1001 (2006).
   PubMed Web of Science ®Google Scholar
• Smith MZ, Dale CJ, De Rose R et al. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol.79(2), 684–695 (2005).
   PubMed Web of Science ®Google Scholar
• Cranage MP, Cook N, Johnstone P et al. SIV infection of rhesus macaques: in vivo titration of infectivity and development of an experimental vaccine. In: Animal Models in AIDS. Schellekens H, Horzinek MC (Eds). Elsevier, Amsterdam, The Netherlands (1990).
   Google Scholar
• Rud EW, Cranage M, Yon J et al. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol.75(Pt 3), 529–543 (1994).
   PubMedGoogle Scholar
• Polyanskaya N, Sharpe S, Cook N et al. Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. AIDS Res. Hum. Retroviruses13(11), 923–931 (1997).
   PubMedGoogle Scholar
• Benveniste RE, Arthur LO, Tsai CC et al. Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses. J. Virol.60(2), 483–490 (1986).
   PubMedGoogle Scholar
• Kuller L, Benveniste RE, Tsai CC et al. Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS. J. Med. Primatol.23(7), 397–409 (1994).
   PubMed Web of Science ®Google Scholar
• Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature339(6223), 389–392 (1989).
   PubMed Web of Science ®Google Scholar
• Gormus BJ, Martin LN, Baskin GB. A brief history of the discovery of natural simian immunodeficiency virus (SIV) infections in captive sooty mangabey monkeys. Front. Biosci.9, 216–224 (2004).
   PubMedGoogle Scholar
• Fultz PN, Su L, May P, West JT. Isolation of sooty mangabey simian T-cell leukemia virus type I [STLV-I(sm)] and characterization of a mangabey T-cell line coinfected with STLV-I(sm) and simian immunodeficiency virus SIVsmmPBj14. Virology235(2), 271–285 (1997).
   PubMedGoogle Scholar
• Lu Y, Pauza CD, Lu X, Montefiori DC, Miller CJ. Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.19(1), 6–18 (1998).
   PubMedGoogle Scholar
• Luciw PA, Pratt-Lowe E, Shaw KE, Levy JA, Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl Acad. Sci. USA92(16), 7490–7494 (1995).
   PubMed Web of Science ®Google Scholar
• Harouse JM, Gettie A, Eshetu T et al. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J. Virol.75(4), 1990–1995 (2001).
   PubMed Web of Science ®Google Scholar
• Derby NR, Kraft Z, Kan E et al. Antibody responses elicited in macaques immunized with human immunodeficiencyvirus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection. J. Virol.80(17), 8745–8762 (2006).
   PubMedGoogle Scholar
• Raghavan R, Stephens EB, Joag SV et al. Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques. Brain Pathol.7(3), 851–861 (1997).
   PubMedGoogle Scholar
• Pal R, Taylor B, Foulke JS et al. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L. J. Acquir. Immune Defic. Syndr.33(3), 300–307 (2003).
   PubMedGoogle Scholar
• Song RJ, Chenine AL, Rasmussen RA et al. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian–human immunodeficiency virus encoding HIV clade C Env. J. Virol.80(17), 8729–9738 (2006).
   PubMed Web of Science ®Google Scholar
• Chen Z, Huang Y, Zhao X et al. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J. Virol.74(14), 6501–6510 (2000).
   PubMedGoogle Scholar